It's been a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
Pregnant women do not believe that noninvasive prenatal testing (NIPT) is an obligation of responsible motherhood, according to a qualitative study that investigated the impact of NIPT on women's moral beliefs about the meaning of prenatal screening.
A same-day blood test that can rule out preeclampsia in pregnant women is being rolled out across the National Health Service (NHS) in England.
When a pregnant woman declines recommended treatment or requests treatment that her care provider does not support, tension can arise.
Contemporary OB/GYN® Editor in Chief Catherine Y. Spong, MD, has been appointed Chair of the Department of Obstetrics and Gynecology at UT Southwestern Medical Center in Dallas, Texas, as of September 1. Spong will hold the Paul C. McDonald Distinguished Chair in Obstetrics and Gynecology, according to a press release.
The American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists (ACOG), the American College of Physicians, the American Osteopathic Association, and the American Psychiatric Association released a statement today in opposition of Senate Bill 8 (SB 8), which is also known as the Texas Heartbeat Act.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More